title: The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder.
authors.forename: D Howard
authors.initials: DH
authors.lastname: Lysne
authors.forename: Thomas
authors.initials: T
authors.lastname: Peterson
authors.forename: Keith
authors.initials: K
authors.lastname: Erickson
authors.forename: Michael
authors.initials: M
authors.lastname: Uriell
mesh_terms: D000293:Adolescent; D017668:Age of Onset; D000927:Anticonvulsants / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D015897:Comorbidity; D039721:Diagnostic and Statistical Manual of Mental Disorders; D006801:Humans; D000078330:Oxcarbazepine; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D002220:Carbamazepine; D000078330:Oxcarbazepine